Frontiers in Pharmacology | Cardiovascular and Smooth Muscle Pharmacology

Review

Published on 10 Apr 2025

Effects of Chinese Medicine on modulating interleukin-17-regulated macrophages in coronary heart disease

in Cardiovascular and Smooth Muscle Pharmacology

Qingqing Liu
Peizhong Liu
Chuangpeng Li
Zhen Zhao
Dawei Wang
Qing Liu
Huawei Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1499786

125 views

Mini Review

Accepted on 08 Apr 2025

Cardiovascular Toxicities Associated with Chimeric Antigen Receptor T Cell Therapy

in Cardiovascular and Smooth Muscle Pharmacology

Xin Zhou
Jiu-Hui Liu
Kun-Yao Liu
Xiang Zhao
Yichuan Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1578157

Mini Review

Accepted on 08 Apr 2025

The Role of Statins in the Regulation of Breast and Colorectal Cancer and Future Directions

in Cardiovascular and Smooth Muscle Pharmacology

Yexing Dang
Yu Zhang
Zhihao Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1578345

Review

Accepted on 07 Apr 2025

The Biology of Exosomes and Exosomal Non-coding RNAs in Cardiovascular Diseases

in Cardiovascular and Smooth Muscle Pharmacology

Lu Gan
Xiaofei Guo
Shichao Dong
Chuan Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1529375

Mini Review

Accepted on 07 Apr 2025

The functional significance of vascular DNA hypermethylation in atherosclerosis: a historical perspective

in Cardiovascular and Smooth Muscle Pharmacology

Silvio Zaina

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1562674

Review

Accepted on 07 Apr 2025

The Role of Exosomes Derived from Macrophages in the Progression of Cardiovascular Disease through Physiological Processes

in Cardiovascular and Smooth Muscle Pharmacology

WENJIE HE
De-Zhu Luo
Huli Li
Yan Jianwen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1563800

Review

Accepted on 07 Apr 2025

NLRP3 inflammasome as a therapeutic target in doxorubicin-induced cardiotoxicity: Role of phytochemicals

in Cardiovascular and Smooth Muscle Pharmacology

Xiaopeng Zhao
Lian Duan
Qian-Ru Zhao
Xing Lv
Nai-Yuan Tian
Yang Shenglei
Kun Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1567312

Original Research

Accepted on 07 Apr 2025

Clusterin ameliorates diabetic atherosclerosis by suppressing macrophage pyroptosis and activation

in Cardiovascular and Smooth Muscle Pharmacology

Lingling Xuan
Lulu Ren
Xiaoxu Kang
Rui Chang
Wen Zhang
Lili Gong
Lihong Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1536132

Review

Published on 04 Apr 2025

Acacetin as a natural cardiovascular therapeutic: mechanisms and preclinical evidence

in Cardiovascular and Smooth Muscle Pharmacology

Zihe Zhou
Tao Li
Helin Qin
Xinyu Wang
Shanshan He
Zhongcai Fan
Qiang Ye
Yanfei Du

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1493981

198 views

Original Research

Accepted on 03 Apr 2025

Pulmonary Artery-Targeted Low-Dose Metformin-Loaded Nanocapsules Safely Improve Pulmonary Arterial Hypertension in Rats

in Cardiovascular and Smooth Muscle Pharmacology

Ayako Chida-Nagai
Naoki Masaki
Hiroki Sato
Tatsuya Kato
Emi Takakuwa
Yoshihiro Matsuno
Atsushi Manabe
Atsuhito Takeda

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1577570

Original Research

Accepted on 03 Apr 2025

Major Risk Factors Underlying the Development of Metabolic Syndrome in Vitamin D-Deficient Rats

in Cardiovascular and Smooth Muscle Pharmacology

Fatemah O Kamel
Shereen K Mahjoub
Mai A A Sattar Ahmad
Maha H Jamal
Duaa M Bakhshwin
Abdulhadi S Burzangi
Soad A Shaker
Rania M Magadmi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1573332

Review

Published on 02 Apr 2025

Traditional Chinese medicine compounds modulate signaling pathways to improve cardiac-related pathology

in Cardiovascular and Smooth Muscle Pharmacology

Luwen Zhang
Wei Wang
Xincan Liu
Kuipo Yan
Qiang Li
Ming Li
Chunying Li
Yanxin Li
Lei Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1499060

186 views

Original Research

Published on 02 Apr 2025

LncRNA MEG3 exacerbates diabetic cardiomyopathy via activating pyroptosis signaling pathway

in Cardiovascular and Smooth Muscle Pharmacology

Shengnan Zhuo
Yifeng Liu
Siyuan Wang
Zhuoling Chen
Xuran Shi
Yangjunna Zhang
Dengfeng Xu
Jingjin Hu
Yin Wang
Xuefeng Qu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1538059

201 views

Original Research

Published on 01 Apr 2025

Deciphering the causality of gut microbiota, circulating metabolites and heart failure: a mediation mendelian

in Cardiovascular and Smooth Muscle Pharmacology

Xueqing Guan
Chaonan Sun
Jianyao Su
Zhijun Sun
Cheng Cheng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1531384

176 views

Original Research

Accepted on 31 Mar 2025

Cardiac protection of wogonin in mice with pulmonary fibrosis by regulating Sirt1/ γ-H2AX pathway

in Cardiovascular and Smooth Muscle Pharmacology

Libo Wang
Fei Lin
Runran Miao
Tianhao Zhao
Yuan Liu
Lin Yang
Min Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1551141

Original Research

Published on 31 Mar 2025

Mendelian randomization study highlights the role of hematological traits on Type-2 diabetes mellitus in African ancestry individuals

in Cardiovascular and Smooth Muscle Pharmacology

Chisom Soremekun
Daudi Jjingo
David Kateete
Oyekanmi Nash
Dorothea Nitsch
Moffat Nyirenda
Dipender Gill
Eleftheria Zeggini
Harald Grallert
Annette Peters

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1436972

305 views